Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.
about
Halofuginone Synergistically Enhances Anti-Proliferation of Rapamycin in T Cells and Reduces Cytotoxicity of Cyclosporine in Cultured Renal Tubular Epithelial CellsHalofuginone inhibits the establishment and progression of melanoma bone metastases.Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.Halofuginone down-regulates Smad3 expression and inhibits the TGFbeta-induced expression of fibrotic markers in human corneal fibroblasts.Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model.Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastasesHalofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism.Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft modelPlant-derived anticancer agents: a promising treatment for bone metastasis.Halofuginone - the multifaceted molecule.Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.Evaluation and Elucidation Studies of Natural Aglycones for Anticancer Potential using Apoptosis-Related Markers: An In silico Study.Ubiquitin enzymes in the regulation of immune responses.The effect of antifibrotic drug halofugine on Th17 cells in concanavalin A-induced liver fibrosis.
P2860
Q28551630-CF484D77-187E-442D-99A1-956D42DFDBF7Q30393926-9D4D72FD-4971-4954-AF43-4F13E135000EQ34657243-ED53980A-CACD-4280-AA45-8A23EB0A9642Q35794257-2C76AE78-A455-427B-BC39-FC5394E69A82Q35800540-AC0FEE28-0C75-4B95-AC77-2E007FB3A816Q35987375-C165E536-1D35-4E83-AC5E-05FFC632AE87Q36414403-6197CA3D-6226-4C1C-8699-792D88CB5FC0Q36991838-437F155E-9D82-4D58-BBE1-9C476480DF1BQ37640924-9AEE2DEA-009D-4603-8BBA-E2AB575BF8EAQ38311322-D0E8FCF5-E692-4B66-86BB-421516078633Q38793565-B3476DDF-AF25-478D-B6FF-31E6A07DE45FQ39317652-290A8025-6274-423F-8873-4B03D8FA7AD5Q39317949-72CA85DE-F4A4-4ABB-82DB-CFF82AA521A1Q51761921-8CA00E13-2360-4889-8A22-01D9868C7763
P2860
Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@ast
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@en
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@nl
type
label
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@ast
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@en
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@nl
prefLabel
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@ast
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@en
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@nl
P2093
P2860
P50
P1433
P1476
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@en
P2093
Aglair B Garcia
Amélia G Araújo
Ana Sílvia G Lima
Arnon Nagler
Bárbara A A Santana-Lemos
Carolina H Thomé
Lorena L de Figueiredo-Pontes
Marco A Zago
Patricia A Assis
Rafael H Jácomo
P2860
P304
P356
10.1371/JOURNAL.PONE.0026713
P407
P577
2011-10-28T00:00:00Z